Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Abstract
Understanding pathophysiology and identifying mothers at risk of major pregnancy complications is vital to effective prevention and optimal management. However, in current antenatal care, understanding of pathophysiology of complications is limited. In gestational diabetes mellitus (GDM), risk prediction is mostly based on maternal history and clinical risk factors and may not optimally identify high risk pregnancies. Hence, universal screening is widely recommended. Here, we will explore the literature on GDM and biomarkers including inflammatory markers, adipokines, endothelial function and lipids to advance understanding of pathophysiology and explore risk prediction, with a goal to guide prevention and treatment of GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Asemi, Z., Hashemi, T., Karamali, M., Samimi, M., & Esmaillzadeh, A. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.072785 · Cited by 202 · cited 1×
“A randomised controlled trial (RCT) of 56 women with GDM diagnosed at 24–28 weeks gestation randomised to calcium plus 25-OHD (50,000 international units (IU) at baseline and day 21) compared to placebo, found a significant reduction in fasting glucose, serum insulin levels, HOMA-IR, and a significant increase in the…”
MethodRetractedDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390 · cited 2×
“GDM is a condition of carbohydrate intolerance with onset or first recognition in pregnancy [44].”
BackgroundClassification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · cited 1×
“This is supported by cross-sectional [23–28] and prospective [25,29–33] studies of associations between increased markers of inflammation and obesity, insulin resistance and/or T2DM.”
ResultTLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690 · cited 1×
“Increased FFAs from enlarged adipocytes act as ligands for toll-like receptors (TLRs) and induce production of inflammatory cytokines from macrophages through activation of the nuclear factor-κB (NF-κB) pathway, which has been shown to be related to insulin resistance [17,21,22].”
BackgroundEffect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358 · cited 1×
“This is supported by cross-sectional [23–28] and prospective [25,29–33] studies of associations between increased markers of inflammation and obesity, insulin resistance and/or T2DM.”
Result
Cited by
Pellonperä, O., Mokkala, K., Houttu, N., Vahlberg, T., Koivuniemi, E., Tertti, K., Rönnemaa, T., & Laitinen, K. (2019) · Diabetes Care · doi:10.2337/dc18-2591 · Cited by 145
Pathirana, M. M., Ali, A., Lassi, Z. S., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2022) · Journal of Human Lactation · doi:10.1177/08903344211034779 · Cited by 29
Non-pharmacological management of gestational diabetes: The role of myo-inositol
Guardo, F. D., Currò, J. M., Valenti, G., Rossetti, P., Di Gregorio, L. M., Conway, F., Chiofalo, B., Garzon, S., Bruni, S., & Rizzo, G. (2020) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2019-0111 · Cited by 14
“In addition, tumor necrosis factor-α (TNF-α) influences hyperglycemia, thus interfering with insulin receptor signaling and β-cell function [18, 22].”
BackgroundBiomarkers of Gestational Diabetes Mellitus: Mechanisms, Advances, and Clinical Utility
Pramodkumar, T. A., Hannah, W., Anjana, R. M., Ram, U., Tiwaskar, M., Gokulakrishnan, K., Popova, P. V., & Mohan, V. (2025) · Journal of The Association of Physicians of India · doi:10.59556/japi.73.0849 · Cited by 7
“70,47 CRP, through its interaction with endothelial cells, promotes vascular inflammation, oxidative stress, and dysregulation of insulin signaling pathways.”
Metadata
- Authors
- Abell, S., De Courten, B., Boyle, J., & Teede, H.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2015-06-11
- Volume
- 16
- Issue
- 6
- Pages
- 13442-13473
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2164974383
- Cited by
- 239
- References
- 149
- FWCI
- 15.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.